Board of Directors
Roger J. Sippl
Chairman of the Board
Allocade, Inc.
Roger Sippl is a Silicon Valley software pioneer, entrepreneur and innovator. His 30 years of contributions have helped shape the enterprise software technology landscape of today. In 1980 he founded Informix Software, and was CEO for 10 years, taking it public in 1986. Under his leadership, Informix, now a part of IBM, pioneered SQL relational database technology for open systems. Mr. Sippl was also co-founder and Chairman of The Vantive Corporation, which became a leader in CRM, went public in 1995, and is now a part of PeopleSoft/Oracle. In 1993, he founded and was CEO of Visigenic Software, helping pioneer distributed object computing and the concept of the application server. Visigenic went public in 1998.
In the mid-nineties, Mr. Sippl became a founding partner of Sippl Macdonald Ventures. He invested in several successful software companies, including Illustra (acquired by Informix), Broadvision (IPO), SupportSoft (board seat and IPO) and Red Pepper (acquired by PeopleSoft). Other investments included Talarian, a messaging company (IPO, now part of Tibco), TimesTen, a main memory DBMS company (now part of Oracle) and Cloudscape, the first all-Java DBMS (acquired by Informix).
In 2008 he founded Elastic Intelligence specifically to provide a hosted and scalable report writer and other business intelligence modules to SaaS companies on a white-labeled basis. In addition to his work with Elastic Intelligence and Allocade, Mr. Sippl currently serves on the boards of Filtini (private) and SolarWinds (NYSE:SWI).
Mr. Sippl studied Biochemistry, Immunology and Computer Science at the University of California at Berkeley, earning a BS degree in Computer Science in 1977.
Annette Bianchi
Managing Director and Group Leader, Healthcare
VantagePoint Capital Partners
Annette Bianchi joined VantagePoint Capital Partners in 2004 and leads the Healthcare Practice Group. She has 24 years of venture capital experience, with significant expertise in all areas of healthcare investing, including medical devices, biotechnology, and healthcare information technology and services. She began her career in venture capital in 1985 at Burr, Egan, Deleage & Company, later joining Weiss, Peck & Greer Venture Partners as a General Partner. In 1999, she became a Managing Director at Pacific Venture Group.
Annette is a graduate of University of Pennsylvania (BSE and MSE in Biomedical Engineering) and The Wharton School (MBA).
David E. Gold
Founding General Partner
Suez Ventures
David E. Gold was founding General Partner of Suez Ventures from its inception in 1985. The partnership managed three funds, which made successful investments in many Silicon Valley companies including Cisco Systems, Sierra Semiconductor, Informix, AccelGraphics, Talarian, LoopNet and Omeros.
David's previous career includes a consulting practice specializing in technology evaluation for venture capital firms. Prior to this, he served a five-year sentence with an upstate New York-based typewriter manufacturer, International Business Machines.
David has a BSEE and MS and PhD degrees in Computer Science from the University of Illinois. He has also authored or co-authored over a dozen published technical papers. David has given dozens of presentations on VC investing in software businesses, with particular focus on vertical market opportunities, and he published the newsletter Vertical Market Report in the 1980s covering this niche.
Eve Kurtin
Senior Advisor
VantagePoint Capital Partners
Eve Kurtin joined VantagePoint Capital Partners from Pacific Venture Group (PVG), where she was Managing Director, and brings more than 20 years of experience to the firm as an operating executive and investor in healthcare. Prior to PVG, she was the founder and CEO of Physician Venture Management, and was a Vice President of American Medical International (Tenet). She currently serves on the Board of the American Physician Foundation and is a founding member of the RAND Health Board of Advisors.
Eve is a graduate of the University of California, Los Angeles (MBA) and the University of Pacific (PharmD).
Henry Wilder
Director
Venture Capital Investor
Henry Wilder has over 30 years of industry and venture investing experience. Before co-founding Dougery and Wilder in 1981 he was with Citicorp Venture Capital. Dougery & Wilder was a traditional institutional venture series of funds investing in West Coast high technology companies from 1981-1998. For the past 13 years, Henry has focused on seed and start up stage medical and software companies: a professional “angel” investor. He has been an early investor in over 100 companies including Caremark, Amgen, Microgenics, Indigo Medical, Leap Frog, Red Envelope, Neurex, Placeware Meeting, In Focus, Alantec and Exodus. Mr. Wilder is currently on the board of three venture companies: Allocade, Concerro, and Rising Data Solutions. He is also a significant and founding investor in Cameron Health.
Henry earned his BS degree from the United States Naval Academy and an MBA from Stanford.
Gary E. Wright
President and Chief Executive Officer (CEO)
Allocade, Inc.
Gary Wright joined Allocade in January 2011 as president and chief executive officer, bringing with him 36 years of experience in the healthcare industry. Before joining Allocade, Gary served as president and chief executive officer for VasoNova, Inc., a healthcare start-up that created the first Doppler/ECG guidance system for PICC catheter and CVC placement, which recently sold to Teleflex Incorporated. Prior to this, Gary was executive vice president of Omnicell, Inc. During his tenure as vice president of sales, the company won the Deloitte Touche Fast 50™ award for its explosive revenue growth five years in a row. Before joining Omnicell, Gary served as vice president and general manager for PCS Health Systems, and prior to this he was an executive with Caremark. Gary also held senior sales positions at leading healthcare companies including Medtronic and American Hospital Supply. He began his career while in college working as an ambulance technician, followed by one year as a registered nurse in the medical intensive care unit at Rush Presbyterian St. Luke's Medical Center in Chicago.
Gary holds a Bachelor of Science from Northern Illinois University and he completed the MedPrep Program at Southern Illinois University School of Medicine. Gary also completed several executive education programs through the University of Virginia, U.C. Berkeley, USC, MIT, Berlitz and Stanford University.